Severity of Atelectasis during Bronchoscopy: Descriptions of a New Grading System (

atelectasis bronchoscopy general anesthesia

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
16 Jan 2024
Historique:
received: 14 11 2023
revised: 02 01 2024
accepted: 04 01 2024
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

Atelectasis during bronchoscopy under general anesthesia is very common and can have a detrimental effect on navigational and diagnostic outcomes. While the intraprocedural incidence and anatomic location have been previously described, the severity of atelectasis has not. We reviewed chest CT images of patients who developed atelectasis in the VESPA trial (Ventilatory Strategy to Prevent Atelectasis). By drawing boundaries at the posterior chest wall (A), the anterior aspect of the vertebral body (C), and mid-way between these two lines (B), we delineated at-risk lung zones 1, 2, and 3 (from posterior to anterior). An Atelectasis Severity Score System ("ASSESS") was created, classifying atelectasis as "mild" (zone 1), "moderate" (zones 1-2), and "severe" (zones 1-2-3). A total of 43 patients who developed atelectasis were included in this study. A total of 32 patients were in the control arm, and 11 were in the VESPA arm; 20 patients (47%) had mild atelectasis, 20 (47%) had moderate atelectasis, and 3 (6%) had severe atelectasis. A higher BMI was associated with increased odds (1.5 per 1 unit change; 95% CI, 1.10-2.04) (

Identifiants

pubmed: 38248073
pii: diagnostics14020197
doi: 10.3390/diagnostics14020197
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Auteurs

Asad Khan (A)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Sami Bashour (S)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Bruce Sabath (B)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Julie Lin (J)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Mona Sarkiss (M)

Department of Anesthesia and Peri-Operative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Juhee Song (J)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Ala-Eddin S Sagar (AS)

Department of Internal Medicine, King Faisal Specialist Hospital and Research Center, Madinah 42523, Saudi Arabia.

Archan Shah (A)

Department of Onco-Medicine, Banner MD Anderson Cancer Center, Gilbert, AZ 85234, USA.

Roberto F Casal (RF)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH